Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/NY/Syracuse
Updated July 2026 from ClinicalTrials.gov

Paid Clinical Trials in Syracuse, NY

Studies commonly pay $75 to $4,500 per completed study

256 clinical trials are currently recruiting participants within 30 miles of Syracuse. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

256studies recruiting
9+research centers nearby
2condition categories
Live from the NIH registry

Studies recruiting near Syracuse right now

Top 25 of 256 recruiting studies, sorted by proximity — each links to its official registry page

A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy

Geographic Atrophy, Macular Degeneration N/A Observational 500 participants sought
Retina-Vitreous Surgeons of Central NY — Liverpool, New York (5.9 mi) · Sponsor: Astellas Pharma Global Development, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06779773)

Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease

Aortoiliac Occlusive Disease N/A Observational 158 participants sought
Research Foundation at SUNY Syracuse — Syracuse, New York (0.5 mi) · Sponsor: W.L.Gore & Associates
See eligibility & contact on ClinicalTrials.gov (NCT06872905)

A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

Non-Muscle Invasive Bladder Neoplasms N/A Observational 150 participants sought
SUNY Upstate Med Univ — Syracuse, New York (0.5 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07309445)

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Advanced/Metastatic Solid Tumors, Colorectal Cancer Phase 1, Phase 2 Interventional 523 participants sought
Hematology-Oncology Associates of Central New York — Syracuse, New York (0.5 mi) · Sponsor: Merus B.V.
See eligibility & contact on ClinicalTrials.gov (NCT03526835)

Educational Discharge Video Impact on Post-Operative Healthcare Utilization After HoLEP

HoLEP, Patient Satisfaction N/A Interventional 114 participants sought
Scott SUNY Upstate Medical University — Syracuse, New York (0.5 mi) · Sponsor: University of California, San Francisco
See eligibility & contact on ClinicalTrials.gov (NCT06975033)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ganglioneuroblastoma, Nodular, Neuroblastoma Phase 3 Interventional 478 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06172296)

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma Phase 3 Interventional 1,450 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT04566328)

A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy

Chronic Myelogenous Leukemia - Chronic Phase N/A Observational 1,000 participants sought
SUNY Upstate Medical University — Syracuse, New York (0.5 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT07091019)

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms Phase 3 Interventional 1,314 participants sought
Associated Medical Professionals - Urology ( Site 0081) — Syracuse, New York (0.5 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06136650)

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma Phase 3 Interventional 255 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07198074)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05564390)

PEG3350 vs Senna After Urogyn Surgery

Obstructive Defecation Syndrome, Postoperative Constipation Phase 4 Interventional 254 participants sought
St. Joseph's Health Hospital — Syracuse, New York (0.5 mi) · Sponsor: St. Joseph's Health, New York
See eligibility & contact on ClinicalTrials.gov (NCT06825260)

A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

Breast Cancer, Early Breast Cancer Phase 3 Interventional 4,300 participants sought
Research Site — East Syracuse, New York (3.7 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT05774951)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT01810913)

Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

Brain Metastases Phase 3 Interventional 206 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi) · Sponsor: Canadian Cancer Trials Group
See eligibility & contact on ClinicalTrials.gov (NCT03550391)

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Ovarian Carcinoma N/A Interventional 1,956 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04251052)

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)

Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD Phase 3 Interventional 284 participants sought
Adverum Clinical Site 225 — Liverpool, New York (5.9 mi) · Sponsor: Adverum Biotechnologies, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07482176)

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma Phase 3 Interventional 62 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT05235165)

Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma Phase 2 Interventional 80 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT02981628)

A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

B-Cell Non-Hodgkins Lymphoma Phase 2 Interventional 100 participants sought
Hematology Oncology Associates of Central New York — East Syracuse, New York (3.7 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06806033)

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

Oligometastatic Prostate Cancer (OMPC) Phase 3 Interventional 450 participants sought
Associated Med Professionals of NY — Syracuse, New York (0.5 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT05939414)

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Prostate Cancer Phase 3 Interventional 940 participants sought
Associated Med Professionals of NY — Syracuse, New York (0.5 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06855277)

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

Non-muscle Invasive Bladder Cancer Phase 1 Interventional 294 participants sought
Upstate Specialty Services at Harrison Center — Syracuse, New York (0.5 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07206225)
Google-rated

Top-rated research centers in Syracuse

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Developmental Psychology Clinical Research Center

Syracuse, NY 13210

Ichor Research

★ 5.0
1101 Erie Blvd E #201, Syracuse, NY 13210
(315) 904-5004
"Christy and team were great. No wait, when I got there. Everything explained clear and to the point. And at least gor why I was there ...great to get…"
— Michael Gilman, 5★

Velocity Clinical Research

★ 4.2
5000 Brittonfield Pkwy Ste B105, East Syracuse, NY 13057
(315) 760-5905
"Excellent staff, communication and access to information. Would gladly participate again in other trials!"
— Suzi Harriff, 5★

Crouse Hospital

★ 3.1
736 Irving Ave, Syracuse, NY 13210
(315) 470-7111

Upstate Biotech Accelerator

★ 4.7
841 E Fayette St, Syracuse, NY 13210
(315) 464-9288
"Well developed, entrepreneurial space."
— Ty A. Austin, 5★

Upstate Health Care Center

★ 4.1
90 Presidential Plaza, Syracuse, NY 13202
(315) 464-5240
"Dr. Carhart and his staff are fabulous, very kind. Dr. Carhart always has a great smile, is kund and never rushes uou. He answers all your questions…"
— Linda Tomczyk, 5★

Central NY Clinical Research

4500 Pewter Ln #2, Manlius, NY 13104
(315) 682-3263

Syracuse VA Medical Center

★ 3.9 (254 reviews)
800 Irving Ave, Syracuse, NY 13210
(315) 425-4400
"This place hasn’t changed in years. It’s just as terrible now as it was when my grandfather was neglected there years ago. Today, patients sit in the…"
— Tricia Loomis, 1★

Associated Medical Professionals of NY, Syracuse

★ 4.8
1226 E Water St Ste D, Syracuse, NY 13210
(315) 478-4185
"Sara knows her stuff! She’s very nice and great to be one of her patients."
— Vicki Vescio, 5★

Clinical trials in Syracuse: what's recruiting

The Syracuse area currently has 256 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Syracuse, the most active research areas are:

  • Cancer & Oncology16 studies
  • Heart & Vascular1 studies

Every listing shows the study phase, the recruiting site and its distance from Syracuse, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Syracuse

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Syracuse participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Syracuse pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Syracuse safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Syracuse?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Syracuse typically complete one or two studies per year.

Paid clinical trials near Syracuse

Other metros within reach

Binghamton, NY18 Rochester, NY459 Scranton, PA100 Albany, NY192 Allentown, PA236 Poughkeepsie, NY73 Buffalo, NY520 Reading, PA281

More of NY

Staten Island4,243 Brooklyn4,241 New York4,179 Manhattan4,173 Bronx4,155 Queens4,142 Yonkers4,130 Buffalo520 Rochester459 Albany192 Poughkeepsie73

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts